Akcea’s mission is to transform the treatment landscape for kidney disease by developing therapeutics

Akcea’s mission is to transform the treatment landscape for kidney disease by developing therapeutics that address unmet medical needs and improve patient outcomes. The company envisions a future where patients with kidney disease have access to effective treatments that enhance their quality of life and set new standards of care. Akcea’s deep roots in the renal community are reflected in its focus on nephrology. The company is committed to understanding the unique challenges faced by patients with kidney disease and developing therapies that address these needs. By combining its expertise in RNA−targeted therapeutics with a strong commitment to patient care, Akcea is able to drive innovation in renal treatment.